Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy

Fabian Zohren, Ingmar Bruns, Sabrina Pechtel, Thomas Schroeder, Roland Fenk, Akos Czibere, Georg Maschmeyer, Dorothea Kofahl-Krause, Norbert Niederle, Gerhard Heil, Christoph Losem, Manfred Welslau, Wolfram Brugger, Ulrich Germing, Ralf Kronenwett, Juergen Barth, Mathias J. Rummel, Rainer Haas, Guido Kobbe

Blood (2015) 126 (12): 1407–1414.

https://doi.org/10.1182/blood-2015-03-630012

Published: 2015

Includes: Supplemental data

Journal Articles

Quantitative Real-Time PCR of Peripheral Blood t(14;18) Positive Cells Predicts Treatment Response and Long-Term Outcome in Patients with Follicular Lymphoma.

Fabian Zohren, Ingmar Bruns, MD, PhD, Juergen Barth, Sabrina Pechtel, Roland Fenk, Thomas Schroeder, Akos G. Czibere, MD, Georg Maschmeyer, Dorothea Kofahl-Krause, Gerhard Heil, Norbert Niederle, Christoph Losem, Manfred Welslau, Ulrich Germing, Ralf Kronenwett, Rainer Haas, Mathias J Rummel, MD, PhD, Guido Kobbe, MD

Blood (2009) 114 (22): 441.

https://doi.org/10.1182/blood.V114.22.441.441

Published: 2009

Journal Articles

Neuropeptides Orexin A and B Are Funktionally Aktive in CD34+ Hematopoietic Stem and Progenitor Cells.

Ron-Patrick Cadeddu, Akos G. Czibere, MD, Sebastian Büst, Johannes C Fischer, Ulrich Steidl, MD, PhD, Ralf Kronenwett, Guido Kobbe, MD, Rainer Haas, Ingmar Bruns, MD, PhD

Blood (2009) 114 (22): 4593.

https://doi.org/10.1182/blood.V114.22.4593.4593

Published: 2009

Journal Articles

Transcriptional Changes Induced by Imatinib and Nilotinib in the Chronic Myelogenous Leukemia (CML) Cell Line K562.

Daniela Bruennert, Ingmar Bruns, MD, PhD, Norbert Gattermann, Ralf Kronenwett, Rainer Haas, Frank Neumann

Blood (2009) 114 (22): 4250.

https://doi.org/10.1182/blood.V114.22.4250.4250

Published: 2009

Journal Articles

The Neuropeptides Orexin a and B Have An Impact on Functional Properties of Human CD34+ Stem and Progenitor Cells.

Ingmar Bruns, MD, PhD, Patrick Cadeddu, Sebastian Büst, Boris Goerg, Johannes C Fischer, Oliver Selbach, Ulrich Steidl, MD, PhD, Ralf Kronenwett, Rainer Haas, Guido Kobbe, Akos Czibere, MD, PhD

Blood (2008) 112 (11): 1393.

https://doi.org/10.1182/blood.V112.11.1393.1393

Published: 2008

Journal Articles

Imatinib Induced Molecular Response in CD34+ Hematopoietic Stem and Progenitor Cells of Patients with Chronic Myeloid Leukemia Following the First Week of Therapy

Daniela Bruennert, Akos Czibere, MD, PhD, Ingmar Bruns, MD, PhD, Sabrina Pechtel, Norbert Gattermann, MD, Ralf Kronenwett, Rainer Haas, Neumann Frank

Blood (2008) 112 (11): 3231.

https://doi.org/10.1182/blood.V112.11.3231.3231

Published: 2008

Journal Articles

Hematopoiesis in Chronic Phase CML emerges from Hematopoietic Stem Cells with a Transcriptional Phenotype Resembling Normal Myeloid Progenitor Cells.

Ingmar Bruns, MD, PhD, Akos Czibere, MD, PhD, Patrick Cadeddu, Frederik Roels, Johannes C Fischer, Sebastian Büst, Daniela Brünnert, Ulrich Steidl, MD, PhD, Benedict Brors, Norbert Gattermann, MD, Ralf Kronenwett, Rainer Haas

Blood (2008) 112 (11): 3365.

https://doi.org/10.1182/blood.V112.11.3365.3365

Published: 2008

Journal Articles

Molecular Level of Minimal Residual Disease in Bone Marrow Before High-Dose Therapy and Autologous Stem Cell Transplantation Is a Prognostic Parameter in Patients with Multiple Myeloma.

Roland Fenk, MD, Mark Korthals, Nina Sehnke, Ingmar Bruns, MD, Akos Czibere, MD, Fabian Zohren, Nancy Safaian, Ariane Dienst, Leilani Ruf, MD, Frank Neumann, MD, Rainer Haas, MD, Ralf Kronenwett, MD, Guido Kobbe, MD

Blood (2007) 110 (11): 1496.

https://doi.org/10.1182/blood.V110.11.1496.1496

Published: 2007

Journal Articles

Patient Characteristics Associated with Successful Mobilization of Peripheral Blood Stem and Progenitor Cells Following Cytotoxic Chemotherapy and Peg-G-CSF Stimulation.

Ingmar Bruns, MD, Johannes C. Fischer, MD, Akos G. Czibere, MD, Cangül Kilic, Roland Fenk, MD, Fabian Zohren, MD, Ralf Kronenwett, MD, Rainer Haas, MD, Ralf Kronenwett, MD

Blood (2007) 110 (11): 4920.

https://doi.org/10.1182/blood.V110.11.4920.4920

Published: 2007

Journal Articles

Molecular Signature of Distinct CD34+ Hematopoietic Stem and Progenitor Cell Subsets of Patients with CML in Chronic Phase.

Ingmar Bruns, MD, Akos G. Czibere, MD, Johannes C. Fischer, MD, Ulrich Steidl, MD, PhD, Sabrina Pechtel, Annemarie Koch, Daniela Brünnert, Sebastian Büst, Ron-Patrick Cadeddu, Ralf Kronenwett, MD, Rainer Haas, MD

Blood (2007) 110 (11): 3170.

https://doi.org/10.1182/blood.V110.11.3170.3170

Published: 2007

Journal Articles

Transcriptional Changes Induced by Imatinib and Nilotinib in the Chronic Myelogenous Leukemia (CML) Cell Line K562.

Frank Neumann, MD, Daniela C. Bruennert, Anne-Marie Koch, Ingmar Bruns, MD, Norbert Gattermann, MD, PhD, Ralf Kronenwett, MD, PhD, Rainer Haas, MD, PhD

Blood (2007) 110 (11): 4540.

https://doi.org/10.1182/blood.V110.11.4540.4540

Published: 2007

Journal Articles

High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 × 10 9 /L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

Norbert Gattermann, Johan Billiet, Ralf Kronenwett, Esther Zipperer, Ulrich Germing, Friedel Nollet, Arnold Criel, Dominik Selleslag

Blood (2007) 109 (3): 1334–1335.

https://doi.org/10.1182/blood-2006-05-022491

Published: 2007

Journal Articles

Pegylated G-CSF Mobilizes CD34+ Cells with Different Stem and Progenitor Cell Subsets and Distinct Functional Properties in Comparison with Unconjugated G-CSF.

Ingmar Bruns, MD, Ulrich Steidl, MD, Johannes C. Fischer, MD, Sascha Raschke, Guido Kobbe, PhD, Roland Fenk, MD, Michael Rosskopf, Sabrina Pechtel, Ulrich-Peter Rohr, PhD, Arndt von Haeseler, PhD, Peter Wernet, PhD, Daniel Tenen, PhD, Rainer Haas, PhD, Ralf Kronenwett, PhD

Blood (2006) 108 (11): 3382.

https://doi.org/10.1182/blood.V108.11.3382.3382

Published: 2006

Journal Articles

Molecular Phenotype of Malignant CD34+ Hematopoietic Stem and Progenitor Cells in Chronic Myelogenous Leukemia.

Ralf Kronenwett, MD, Elena Diaz-Blanco, Thorsten Graef, MD, Ulrich Steidl, MD, Slawomir Kliszewski, Ingmar Bruns, Frank Neumann, MD, Simone Bork, Ulf Butterweck, Nicole Roes, Benedikt Brors, PhD, Roland Eils, PhD, Guido Kobbe, MD, Norbert Gattermann, MD, Rainer Haas, MD

Blood (2005) 106 (11): 2863.

https://doi.org/10.1182/blood.V106.11.2863.2863

Published: 2005

Journal Articles

Distinct Gene Expression Pattern of CD34+ Stem and Progenitor Cells Mobilized by Pegfilgrastim after Cytotoxic Therapy in Multiple Myeloma in Comparison to G-CSF.

Ingmar Bruns, MD, Ulrich Steidl, MD, Guido Kobbe, MD, Roland Fenk, MD, Slawomir Kliszewski, Sabrina Pechtel, Rainer Haas, MD, PhD, Ralf Kronenwett, MD, PhD

Blood (2005) 106 (11): 5191.

https://doi.org/10.1182/blood.V106.11.5191.5191

Published: 2005

Journal Articles

Pre-Transplantation Level of Minimal Residual Disease Detected by Quantitative Real-Time IgH-PCR Is a Prognostic Parameter in Patients with Multiple Myeloma.

Roland Fenk, MD, Mark Korthals, Guido Kobbe, MD, Ulrich Steidl, MD, Thorsten Graef, MD, Ulrich-Peter Rohr, MD, Leilani Ruf, MD, Barbara Hoyer, MD, Frank Neumann, MD, Rainer Haas, MD, Ralf Kronenwett, MD

Blood (2004) 104 (11): 4871.

https://doi.org/10.1182/blood.V104.11.4871.4871

Published: 2004

Journal Articles

Gene Expression Profiling of Philadelphia Chromosome(Ph) Negative CD34+ Hematopoietic Stem and Progenitor Cells of Patients with Ph Positive CML in Complete Molecular Remission during Therapy with Imatinib.

Frank Neumann, Nathalie Teutsch, Slawomir Kliszewski, Simone Bork, Benedikt Brors, Nadine Schimkus, Nicole Roes, Ulrich Steidl, Ulrich Germing, PD, Barbara Hildebrandt, Brigitte Royer-Pokora, Roland Eils, Norbert Gattermann, Rainer Haas, Ralf Kronenwett, PD

Blood (2004) 104 (11): 2955.

https://doi.org/10.1182/blood.V104.11.2955.2955

Published: 2004

Journal Articles

Targeted Alpha Radiation and Gamma Rays Induce Distinct and Mutation Status Specific Transcriptional Responses in Human Leukemic Lymphocytes.

Simona Martin, PhD, Ralf Kronenwett, PhD, Katia Vandenbulcke, Fritz Offner, Prof, Slawomir Kliszewski, Christos Apostolidis, PhD, Alfred Morgenstern, PhD, Ulrich Steidl, PhD, Sascha Raschke, Frank Neumann, PhD, Jan Philippe, PhD, Guido Slegers, PhD, Rainer Haas

Blood (2004) 104 (11): 4372.

https://doi.org/10.1182/blood.V104.11.4372.4372

Published: 2004

Journal Articles

Primary human CD34 + hematopoietic stem and progenitor cells express functionally active receptors of neuromediators

Ulrich Steidl, Simone Bork, Sebastian Schaub, Oliver Selbach, Janette Seres, Manuel Aivado, Thomas Schroeder, Ulrich-Peter Rohr, Roland Fenk, Slawomir Kliszewski, Christian Maercker, Peter Neubert, Stefan R. Bornstein, Helmut L. Haas, Guido Kobbe, Daniel G. Tenen, Rainer Haas, Ralf Kronenwett

Blood (2004) 104 (1): 81–88.

https://doi.org/10.1182/blood-2004-01-0373

Published: 2004

Journal Articles

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34 + hematopoietic stem cells

Ulrich Steidl, Ralf Kronenwett, Ulrich-Peter Rohr, Roland Fenk, Slawomir Kliszewski, Christian Maercker, Peter Neubert, Manuel Aivado, Judith Koch, Olga Modlich, Hans Bojar, Norbert Gattermann, Rainer Haas

Blood (2002) 99 (6): 2037–2044.

https://doi.org/10.1182/blood.V99.6.2037

Published: 2002

NARROW

Prognostic value of circulating Bcl-2/IgH levels in patients with follicular lymphoma receiving first-line immunochemotherapy

Quantitative Real-Time PCR of Peripheral Blood t(14;18) Positive Cells Predicts Treatment Response and Long-Term Outcome in Patients with Follicular Lymphoma.

Neuropeptides Orexin A and B Are Funktionally Aktive in CD34+ Hematopoietic Stem and Progenitor Cells.

Transcriptional Changes Induced by Imatinib and Nilotinib in the Chronic Myelogenous Leukemia (CML) Cell Line K562.

The Neuropeptides Orexin a and B Have An Impact on Functional Properties of Human CD34+ Stem and Progenitor Cells.

Imatinib Induced Molecular Response in CD34+ Hematopoietic Stem and Progenitor Cells of Patients with Chronic Myeloid Leukemia Following the First Week of Therapy

Hematopoiesis in Chronic Phase CML emerges from Hematopoietic Stem Cells with a Transcriptional Phenotype Resembling Normal Myeloid Progenitor Cells.

Molecular Level of Minimal Residual Disease in Bone Marrow Before High-Dose Therapy and Autologous Stem Cell Transplantation Is a Prognostic Parameter in Patients with Multiple Myeloma.

Patient Characteristics Associated with Successful Mobilization of Peripheral Blood Stem and Progenitor Cells Following Cytotoxic Chemotherapy and Peg-G-CSF Stimulation.

Molecular Signature of Distinct CD34+ Hematopoietic Stem and Progenitor Cell Subsets of Patients with CML in Chronic Phase.

Transcriptional Changes Induced by Imatinib and Nilotinib in the Chronic Myelogenous Leukemia (CML) Cell Line K562.

High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count > 600 × 10 9 /L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable

Pegylated G-CSF Mobilizes CD34+ Cells with Different Stem and Progenitor Cell Subsets and Distinct Functional Properties in Comparison with Unconjugated G-CSF.

Molecular Phenotype of Malignant CD34+ Hematopoietic Stem and Progenitor Cells in Chronic Myelogenous Leukemia.

Distinct Gene Expression Pattern of CD34+ Stem and Progenitor Cells Mobilized by Pegfilgrastim after Cytotoxic Therapy in Multiple Myeloma in Comparison to G-CSF.

Pre-Transplantation Level of Minimal Residual Disease Detected by Quantitative Real-Time IgH-PCR Is a Prognostic Parameter in Patients with Multiple Myeloma.

Gene Expression Profiling of Philadelphia Chromosome(Ph) Negative CD34+ Hematopoietic Stem and Progenitor Cells of Patients with Ph Positive CML in Complete Molecular Remission during Therapy with Imatinib.

Targeted Alpha Radiation and Gamma Rays Induce Distinct and Mutation Status Specific Transcriptional Responses in Human Leukemic Lymphocytes.

Primary human CD34 + hematopoietic stem and progenitor cells express functionally active receptors of neuromediators

Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow–derived and circulating human CD34 + hematopoietic stem cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only